iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
125.77
+0.45 (0.36%)
Jun 18, 2025, 4:00 PM - Market closed
IBB Holdings List
As of Jun 18, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | GILD | Gilead Sciences, Inc. | 8.33% |
2 | AMGN | Amgen Inc. | 8.29% |
3 | VRTX | Vertex Pharmaceuticals Incorporated | 8.24% |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.21% |
5 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.43% |
6 | IQV | IQVIA Holdings Inc. | 3.09% |
7 | MTD | Mettler-Toledo International Inc. | 2.70% |
8 | ARGX | argenx SE | 2.60% |
9 | NTRA | Natera, Inc. | 2.51% |
10 | WAT | Waters Corporation | 2.31% |
11 | BIIB | Biogen Inc. | 2.11% |
12 | INSM | Insmed Incorporated | 2.02% |
13 | BNTX | BioNTech SE | 1.95% |
14 | ILMN | Illumina, Inc. | 1.63% |
15 | ONC | BeOne Medicines Ltd. | 1.59% |
16 | INCY | Incyte Corporation | 1.49% |
17 | UTHR | United Therapeutics Corporation | 1.47% |
18 | NBIX | Neurocrine Biosciences, Inc. | 1.41% |
19 | EXEL | Exelixis, Inc. | 1.27% |
20 | BMRN | BioMarin Pharmaceutical Inc. | 1.19% |
21 | GMAB | Genmab A/S | 1.14% |
22 | MRNA | Moderna, Inc. | 1.00% |
23 | BPMC | Blueprint Medicines Corporation | 0.92% |
24 | TECH | Bio-Techne Corporation | 0.90% |
25 | MEDP | Medpace Holdings, Inc. | 0.87% |
26 | CRL | Charles River Laboratories International, Inc. | 0.84% |
27 | ASND | Ascendis Pharma A/S | 0.82% |
28 | HALO | Halozyme Therapeutics, Inc. | 0.74% |
29 | RVMD | Revolution Medicines, Inc. | 0.74% |
30 | RGEN | Repligen Corporation | 0.71% |
31 | BBIO | BridgeBio Pharma, Inc. | 0.69% |
32 | IONS | Ionis Pharmaceuticals, Inc. | 0.66% |
33 | TEM | Tempus AI, Inc. | 0.62% |
34 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.60% |
35 | ROIV | Roivant Sciences Ltd. | 0.58% |
36 | ALKS | Alkermes plc | 0.53% |
37 | VRNA | Verona Pharma plc | 0.53% |
38 | LEGN | Legend Biotech Corporation | 0.51% |
39 | PCVX | Vaxcyte, Inc. | 0.48% |
40 | ADMA | ADMA Biologics, Inc. | 0.47% |
41 | AXSM | Axsome Therapeutics, Inc. | 0.47% |
42 | BRKR | Bruker Corporation | 0.45% |
43 | PTCT | PTC Therapeutics, Inc. | 0.44% |
44 | ACAD | ACADIA Pharmaceuticals Inc. | 0.44% |
45 | CYTK | Cytokinetics, Incorporated | 0.43% |
46 | CRSP | CRISPR Therapeutics AG | 0.42% |
47 | AKRO | Akero Therapeutics, Inc. | 0.42% |
48 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.40% |
49 | NUVL | Nuvalent, Inc. | 0.38% |
50 | SWTX | SpringWorks Therapeutics, Inc. | 0.38% |
51 | RNA | Avidity Biosciences, Inc. | 0.37% |
52 | KRYS | Krystal Biotech, Inc. | 0.37% |
53 | RARE | Ultragenyx Pharmaceutical Inc. | 0.37% |
54 | MRUS | Merus N.V. | 0.37% |
55 | PTGX | Protagonist Therapeutics, Inc. | 0.36% |
56 | ZLAB | Zai Lab Limited | 0.32% |
57 | SRRK | Scholar Rock Holding Corporation | 0.30% |
58 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.30% |
59 | ACLX | Arcellx, Inc. | 0.29% |
60 | KYMR | Kymera Therapeutics, Inc. | 0.29% |
61 | XENE | Xenon Pharmaceuticals Inc. | 0.27% |
62 | SMMT | Summit Therapeutics Inc. | 0.27% |
63 | VCEL | Vericel Corporation | 0.24% |
64 | VCYT | Veracyte, Inc. | 0.24% |
65 | TWST | Twist Bioscience Corporation | 0.23% |
66 | MIRM | Mirum Pharmaceuticals, Inc. | 0.23% |
67 | BCRX | BioCryst Pharmaceuticals, Inc. | 0.22% |
68 | AGIO | Agios Pharmaceuticals, Inc. | 0.22% |
69 | SRPT | Sarepta Therapeutics, Inc. | 0.21% |
70 | APLS | Apellis Pharmaceuticals, Inc. | 0.21% |
71 | DNLI | Denali Therapeutics Inc. | 0.20% |
72 | IDYA | IDEAYA Biosciences, Inc. | 0.20% |
73 | FOLD | Amicus Therapeutics, Inc. | 0.19% |
74 | NVCR | NovoCure Limited | 0.19% |
75 | GRFS | Grifols, S.A. | 0.19% |
76 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.19% |
77 | RXRX | Recursion Pharmaceuticals, Inc. | 0.17% |
78 | BEAM | Beam Therapeutics Inc. | 0.17% |
79 | ADPT | Adaptive Biotechnologies Corporation | 0.17% |
80 | APGE | Apogee Therapeutics, Inc. | 0.17% |
81 | ARQT | Arcutis Biotherapeutics, Inc. | 0.16% |
82 | ETNB | 89bio, Inc. | 0.16% |
83 | TARS | Tarsus Pharmaceuticals, Inc. | 0.16% |
84 | GRAL | GRAIL, Inc. | 0.16% |
85 | XTSLA | BLK CSH FND TREASURY SL AGENCY | 0.15% |
86 | BHVN | Biohaven Ltd. | 0.15% |
87 | TVTX | Travere Therapeutics, Inc. | 0.14% |
88 | DVAX | Dynavax Technologies Corporation | 0.14% |
89 | CGON | CG Oncology, Inc. | 0.14% |
90 | STVN | Stevanato Group S.p.A. | 0.13% |
91 | MNKD | MannKind Corporation | 0.13% |
92 | TXG | 10x Genomics, Inc. | 0.13% |
93 | IMVT | Immunovant, Inc. | 0.13% |
94 | JANX | Janux Therapeutics, Inc. | 0.13% |
95 | EWTX | Edgewise Therapeutics, Inc. | 0.12% |
96 | IRON | Disc Medicine, Inc. | 0.12% |
97 | MESO | Mesoblast Limited | 0.12% |
98 | NAMS | NewAmsterdam Pharma Company N.V. | 0.12% |
99 | VERA | Vera Therapeutics, Inc. | 0.12% |
100 | ALVO | Alvotech | 0.11% |
101 | AUPH | Aurinia Pharmaceuticals Inc. | 0.11% |
102 | IMCR | Immunocore Holdings plc | 0.11% |
103 | CDNA | CareDx, Inc | 0.11% |
104 | GLPG | Galapagos NV | 0.11% |
105 | NTLA | Intellia Therapeutics, Inc. | 0.11% |
106 | EVO | Evotec SE | 0.11% |
107 | GERN | Geron Corporation | 0.11% |
108 | NVAX | Novavax, Inc. | 0.11% |
109 | DYN | Dyne Therapeutics, Inc. | 0.10% |
110 | CRMD | CorMedix Inc. | 0.10% |
111 | NRIX | Nurix Therapeutics, Inc. | 0.10% |
112 | WVE | Wave Life Sciences Ltd. | 0.10% |
113 | ZYME | Zymeworks Inc. | 0.10% |
114 | GPCR | Structure Therapeutics Inc. | 0.09% |
115 | SPRY | ARS Pharmaceuticals, Inc. | 0.09% |
116 | SNDX | Syndax Pharmaceuticals, Inc. | 0.09% |
117 | ABCL | AbCellera Biologics Inc. | 0.09% |
118 | SYRE | Spyre Therapeutics, Inc. | 0.09% |
119 | AVXL | Anavex Life Sciences Corp. | 0.09% |
120 | PRAX | Praxis Precision Medicines, Inc. | 0.08% |
121 | VERV | Verve Therapeutics, Inc. | 0.08% |
122 | QURE | uniQure N.V. | 0.08% |
123 | CNTA | Centessa Pharmaceuticals plc | 0.08% |
124 | COGT | Cogent Biosciences, Inc. | 0.08% |
125 | ELVN | Enliven Therapeutics, Inc. | 0.08% |
126 | LENZ | LENZ Therapeutics, Inc. | 0.08% |
127 | ANAB | AnaptysBio, Inc. | 0.08% |
128 | REPL | Replimune Group, Inc. | 0.07% |
129 | XNCR | Xencor, Inc. | 0.06% |
130 | IOVA | Iovance Biotherapeutics, Inc. | 0.06% |
131 | URGN | UroGen Pharma Ltd. | 0.06% |
132 | CSTL | Castle Biosciences, Inc. | 0.06% |
133 | ETR: 5CV | CureVac N.V. | 0.06% |
134 | ALT | Altimmune, Inc. | 0.06% |
135 | ABUS | Arbutus Biopharma Corporation | 0.06% |
136 | MLYS | Mineralys Therapeutics, Inc. | 0.06% |
137 | RCUS | Arcus Biosciences, Inc. | 0.06% |
138 | SAGE | Sage Therapeutics, Inc. | 0.06% |
139 | FTRE | Fortrea Holdings Inc. | 0.06% |
140 | TBPH | Theravance Biopharma, Inc. | 0.06% |
141 | AVBP | ArriVent BioPharma, Inc. | 0.06% |
142 | ZVRA | Zevra Therapeutics, Inc. | 0.06% |
143 | STOK | Stoke Therapeutics, Inc. | 0.06% |
144 | DAWN | Day One Biopharmaceuticals, Inc. | 0.05% |
145 | KALV | KalVista Pharmaceuticals, Inc. | 0.05% |
146 | VIR | Vir Biotechnology, Inc. | 0.05% |
147 | KROS | Keros Therapeutics, Inc. | 0.05% |
148 | ARVN | Arvinas, Inc. | 0.05% |
149 | MYGN | Myriad Genetics, Inc. | 0.05% |
150 | KURA | Kura Oncology, Inc. | 0.05% |
151 | RLAY | Relay Therapeutics, Inc. | 0.05% |
152 | PHAT | Phathom Pharmaceuticals, Inc. | 0.05% |
153 | NUVB | Nuvation Bio Inc. | 0.05% |
154 | TSHA | Taysha Gene Therapies, Inc. | 0.05% |
155 | OPK | OPKO Health, Inc. | 0.05% |
156 | LAB | Standard BioTools Inc. | 0.05% |
157 | FLGT | Fulgent Genetics, Inc. | 0.05% |
158 | ORIC | ORIC Pharmaceuticals, Inc. | 0.04% |
159 | RGNX | REGENXBIO Inc. | 0.04% |
160 | USD | USD CASH | 0.04% |
161 | CTKB | Cytek Biosciences, Inc. | 0.04% |
162 | AUTL | Autolus Therapeutics plc | 0.04% |
163 | ORKA | Oruka Therapeutics, Inc. | 0.04% |
164 | MGTX | MeiraGTx Holdings plc | 0.04% |
165 | EBS | Emergent BioSolutions Inc. | 0.04% |
166 | SANA | Sana Biotechnology, Inc. | 0.04% |
167 | RIGL | Rigel Pharmaceuticals, Inc. | 0.04% |
168 | TRVI | Trevi Therapeutics, Inc. | 0.04% |
169 | PACB | Pacific Biosciences of California, Inc. | 0.04% |
170 | AMLX | Amylyx Pharmaceuticals, Inc. | 0.04% |
171 | DNA | Ginkgo Bioworks Holdings, Inc. | 0.04% |
172 | ITOS | iTeos Therapeutics, Inc. | 0.04% |
173 | SLDB | Solid Biosciences Inc. | 0.04% |
174 | TYRA | Tyra Biosciences, Inc. | 0.04% |
175 | CMPS | COMPASS Pathways plc | 0.03% |
176 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.03% |
177 | HUMA | Humacyte, Inc. | 0.03% |
178 | CGEM | Cullinan Therapeutics, Inc. | 0.03% |
179 | ABSI | Absci Corporation | 0.03% |
180 | PSNL | Personalis, Inc. | 0.03% |
181 | RCKT | Rocket Pharmaceuticals, Inc. | 0.03% |
182 | TNGX | Tango Therapeutics, Inc. | 0.03% |
183 | AURA | Aura Biosciences, Inc. | 0.03% |
184 | ATXS | Astria Therapeutics, Inc. | 0.03% |
185 | TRML | Tourmaline Bio, Inc. | 0.03% |
186 | VNDA | Vanda Pharmaceuticals Inc. | 0.03% |
187 | TERN | Terns Pharmaceuticals, Inc. | 0.03% |
188 | IBRX | ImmunityBio, Inc. | 0.03% |
189 | PRTA | Prothena Corporation plc | 0.03% |
190 | PGEN | Precigen, Inc. | 0.03% |
191 | MRVI | Maravai LifeSciences Holdings, Inc. | 0.03% |
192 | AVIR | Atea Pharmaceuticals, Inc. | 0.03% |
193 | ERAS | Erasca, Inc. | 0.03% |
194 | ADCT | ADC Therapeutics SA | 0.03% |
195 | OLMA | Olema Pharmaceuticals, Inc. | 0.03% |
196 | BCYC | Bicycle Therapeutics plc | 0.02% |
197 | NGNE | Neurogene Inc. | 0.02% |
198 | ANNX | Annexon, Inc. | 0.02% |
199 | QTRX | Quanterix Corporation | 0.02% |
200 | TECX | Tectonic Therapeutic, Inc. | 0.02% |
201 | GLUE | Monte Rosa Therapeutics, Inc. | 0.02% |
202 | EDIT | Editas Medicine, Inc. | 0.02% |
203 | MXCT | MaxCyte, Inc. | 0.02% |
204 | RAPP | Rapport Therapeutics, Inc. | 0.02% |
205 | CDXS | Codexis, Inc. | 0.02% |
206 | SVRA | Savara Inc. | 0.02% |
207 | CRVS | Corvus Pharmaceuticals, Inc. | 0.02% |
208 | ALMS | Alumis Inc. | 0.02% |
209 | ALLO | Allogene Therapeutics, Inc. | 0.02% |
210 | CATX | Perspective Therapeutics, Inc. | 0.02% |
211 | IMMP | Immutep Limited | 0.02% |
212 | INZY | Inozyme Pharma, Inc. | 0.02% |
213 | FDMT | 4D Molecular Therapeutics, Inc. | 0.02% |
214 | YMAB | Y-mAbs Therapeutics, Inc. | 0.02% |
215 | SLN | Silence Therapeutics plc | 0.02% |
216 | TRDA | Entrada Therapeutics, Inc. | 0.02% |
217 | CYBN | Cybin Inc. | 0.02% |
218 | INBX | Inhibrx Biosciences, Inc. | 0.02% |
219 | ENTA | Enanta Pharmaceuticals, Inc. | 0.02% |
220 | SGAFT | CASH COLLATERAL USD SGAFT | 0.02% |
221 | VYGR | Voyager Therapeutics, Inc. | 0.02% |
222 | FHTX | Foghorn Therapeutics Inc. | 0.02% |
223 | CRGX | CARGO Therapeutics, Inc. | 0.01% |
224 | FATE | Fate Therapeutics, Inc. | 0.01% |
225 | ACIU | AC Immune SA | 0.01% |
226 | DSGN | Design Therapeutics, Inc. | 0.01% |
227 | THRD | Third Harmonic Bio, Inc. | 0.01% |
228 | ALEC | Alector, Inc. | 0.01% |
229 | IRWD | Ironwood Pharmaceuticals, Inc. | 0.01% |
230 | LRMR | Larimar Therapeutics, Inc. | 0.01% |
231 | LXEO | Lexeo Therapeutics, Inc. | 0.01% |
232 | PRME | Prime Medicine, Inc. | 0.01% |
233 | RNAC | Cartesian Therapeutics, Inc. | 0.01% |
234 | CCCC | C4 Therapeutics, Inc. | 0.01% |
235 | NKTX | Nkarta, Inc. | 0.01% |
236 | MGNX | MacroGenics, Inc. | 0.01% |
237 | PLRX | Pliant Therapeutics, Inc. | 0.01% |
238 | CLYM | Climb Bio, Inc. | 0.01% |
239 | BMEA | Biomea Fusion, Inc. | 0.01% |
240 | TKNO | Alpha Teknova, Inc. | 0.01% |
241 | KYTX | Kyverna Therapeutics, Inc. | 0.01% |
242 | TCRX | TScan Therapeutics, Inc. | 0.01% |
243 | LYEL | Lyell Immunopharma, Inc. | 0.01% |
244 | STRO | Sutro Biopharma, Inc. | 0.01% |
245 | PYXS | Pyxis Oncology, Inc. | 0.01% |
246 | NMRA | Neumora Therapeutics, Inc. | 0.01% |
247 | PEPG | PepGen Inc. | 0.01% |
248 | APLT | Applied Therapeutics, Inc. | 0.00% |
249 | TVGN | Tevogen Bio Holdings Inc. | 0.00% |
250 | MRSN | Mersana Therapeutics, Inc. | 0.00% |
251 | ACRV | Acrivon Therapeutics, Inc. | 0.00% |
252 | OKUR | OnKure Therapeutics, Inc. | 0.00% |
253 | ARTV | Artiva Biotherapeutics, Inc. | 0.00% |
254 | IGMS | IGM Biosciences, Inc. | 0.00% |
255 | ADRO | CHINOOK THERAPEUTICS INC | 0.00% |
256 | QTTB | Q32 Bio Inc. | 0.00% |
257 | MARGIN_USD | FUTURES USD MARGIN BALANCE | 0.00% |
258 | - | CARTESIAN THERAPEUTICS INC | 0.00% |
259 | - | FUSION PHARMACEUTICALS INC CVR | 0.00% |
260 | - | AKOUOS CVRS Prvt | 0.00% |
261 | - | OMNIAB INC $15.00 VESTING Prvt | 0.00% |
262 | - | OMNIAB INC $12.50 VESTING Prvt | 0.00% |
263 | RTYU5 | RUSSELL 2000 EMINI CME SEP 25 | 0.00% |
264 | IXCU5 | E-MINI HEALTH CARE SECTOR SEP 25 | 0.00% |
As of Jun 18, 2025